ArticleTherapeutic advances in gastroenterology2026
Vedolizumab clinical decision support tool predicts clinically relevant targets in patients with Crohn's disease.
Parambir S Dulai et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.